Insulin resistance and cardiovascular risk in the pediatric patient

J Steinberger1

  • 1Department of Pediatrics, University of Minnesota, 420 Delaware St. SE, 55455, Minneapolis, MN, USA

Insights

Childhood obesity is linked to insulin resistance syndrome, increasing risks for heart disease and diabetes. Weight management in youth can improve insulin sensitivity and cardiovascular health.

Area of Science:

  • Pediatric Endocrinology
  • Cardiovascular Health
  • Metabolic Syndrome

Background:

  • Insulin resistance syndrome, a precursor to cardiovascular disease and type 2 diabetes, comprises hyperinsulinemia, obesity, hypertension, and hyperlipidemia.
  • Increased left ventricular mass is a significant predictor of cardiovascular events, often associated with insulin resistance syndrome.
  • While prevalent in adults, the pathological processes of atherosclerotic cardiovascular disease begin in childhood, with emerging evidence of insulin resistance syndrome components in youth.

Purpose of the Study:

  • To investigate the associations between components of insulin resistance syndrome in children and adolescents.
  • To understand the link between childhood obesity and the development of insulin resistance and associated risk factors.
  • To explore the presence and implications of increased left ventricular mass in childhood related to metabolic risk factors.

Main Methods:

  • Review of recent studies on pediatric populations.
  • Analysis of associations between obesity, insulin resistance, lipid profiles, and blood pressure in young adults.
  • Assessment of left ventricular mass in children and its relation to obesity and insulin resistance.

Main Results:

  • Childhood and adolescent overweight status is significantly associated with insulin resistance, abnormal lipid profiles, and elevated blood pressure in young adulthood.
  • Weight loss in overweight youth leads to decreased insulin levels and improved insulin sensitivity.
  • Increased left ventricular mass is present in childhood and linked to obesity and insulin resistance.

Conclusions:

  • Weight control and lifestyle modifications in children and adolescents can mitigate the incidence of insulin resistance syndrome.
  • Interventions targeting childhood obesity may improve cardiovascular disease risk profiles during the transition to adulthood.
  • Early management of metabolic risk factors in youth is crucial for long-term cardiovascular health.

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.